Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1740-1742
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume5
Issue number6
DOIs
Publication statusPublished - 2017

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this